Description:

RTOG 0825 Phase III GBM Treatment Summary Form (TF) Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=5A7D3B0F-8D23-492E-E044-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=5A7D3B0F-8D23-492E-E044-0003BA3F9857

Keywords:
Versions (4) ▾
  1. 8/26/12
  2. 1/9/15
  3. 1/9/15
  4. 1/9/15
Uploaded on:

January 9, 2015

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Brain and Central Nervous System Tumors NCT00884741 Treatment - RTOG 0825 Phase III GBM Treatment Summary Form (TF) - 2796514v1.0

INSTRUCTIONS: Submit this form at the completion of each cycle of protocol treatment. Dates are to be recorded as mm-dd-yyyy unless otherwise specified

Unnamed Module 1
Assessment
cm
Kg
m2
Disease Progression
Unnamed 3
Protocol Specific Adverse Event Evaluation
seconds
seconds
seconds
seconds
seconds
1000/uL
Protocol Specific Adverse Event Evaluation
Protocol Specific Adverse Event Evaluation
Footer